0001104659-26-070256.txt : 20260603 0001104659-26-070256.hdr.sgml : 20260603 20260603203004 ACCESSION NUMBER: 0001104659-26-070256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260601 FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sarchi Christopher CENTRAL INDEX KEY: 0001986597 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 261062859 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 500 UNICORN PARK DRIVE CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2616801-1_4seq1.xml OWNERSHIP DOCUMENT X0609 4 2026-06-01 1 0001737953 Replimune Group, Inc. REPL 0001986597 Sarchi Christopher false C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK DRIVE, SUITE 303 WOBURN MA 01801 0 1 0 0 Chief Commercial Officer 1 Common Stock 2026-06-01 4 S 0 12000 9.24 D 180962 D The sales reported on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 15, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $9.15 to $9.62 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range. /s/ Shawn Glidden, attorney-in-fact 2026-06-03